The University of Chicago Header Logo

Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer.

Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer. Cancer Sci. 2022 May; 113(5):1808-1820.

View in: PubMed